|
UK Updates Its Guidance on EU Vigilance System
To bring the UK’s guidelines in line with last year’s changes to the EU’s vigilance guidance system, the Medicines and Healthcare Regulatory products Agency (MHRA) updated its guidance on adverse incident reporting.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Related Articles
|
Subscribe
Archives